文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

一氧化氮设备给药模式与呼吸机flow-by对预设浓度输送的影响

Modes of administration of nitric oxide devices and ventilators flow-by impact the delivery of pre-determined concentrations.
PubMed 文献 · Ann Intensive Care · 2024-08-21
一句话结论体外测试显示,仅比例型iNO设备的输送精度不受呼吸机flow-by影响,连续型和吸气同步型在flow-by较高时浓度下降。

该研究在测试肺上评估七种iNO设备与不同ICU呼吸机flow-by组合时达到目标吸气NO浓度的准确性及毒性风险。按NO流量输送方式将设备分为连续型、吸气同步型和比例型三代,中位准确度分别为2%(IQR -19; 36)、-23%(IQR -29; -17)和0%(IQR -2; 0)。呼吸机flow-by增加使连续型和吸气同步型测试肺内iNO浓度下降,比例型不受影响。NO2浓度均未超过预设0.5 ppm安全目标,但19%的配置中NO2≥0.3 ppm,该浓度可致支气管收缩。

要点

  • 比例型iNO设备在各条件下输送浓度准确(中位偏差0%,IQR -2; 0),且不受呼吸机flow-by影响。
  • 连续型设备中位偏差2%(IQR -19; 36),吸气同步型中位偏差-23%(IQR -29; -17),后者明显偏低。
  • 呼吸机flow-by增加时,连续型和吸气同步型设备测试肺内iNO浓度下降,比例型不变。
  • NO2浓度均未超过预设0.5 ppm安全目标,但19%的配置中NO2≥0.3 ppm,该浓度可致支气管收缩。
  • 选择iNO设备时需考虑其工作原理与呼吸机flow-by设置的匹配,比例型在测试条件下输送最稳定。

适用人群与场景

  • 成人ICU中因难治性低氧血症接受机械通气的患者(原文背景所述iNO主要用途)。
  • 本研究为体外测试肺实验,非患者人群。

红旗征与不能漏的情况

  • NO2浓度≥0.3 ppm可致支气管收缩,本研究中19%的配置出现该浓度。

研究设计与关键结果

  • 研究为体外测试肺实验,评估七种iNO设备与四种flow-by水平的ICU呼吸机组合。
  • 按NO流量输送方式分为连续型、吸气同步型(I-Sequential)和比例型三代设备。
  • 测试肺内iNO浓度中位准确度:连续型2%(IQR -19; 36),吸气同步型-23%(IQR -29; -17),比例型0%(IQR -2; 0)。
  • 呼吸机flow-by增加导致连续型和吸气同步型设备测试肺内iNO浓度下降,比例型不受影响。
  • NO2浓度均未超过预设安全目标0.5 ppm,但19%的配置中NO2≥0.3 ppm。

证据类型、等级与局限

  • 证据类型:体外测试肺实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 选择iNO设备时需考虑其工作原理与呼吸机flow-by设置的匹配,比例型设备在测试条件下输送准确且不受flow-by影响。
  • 使用连续型或吸气同步型设备时,呼吸机flow-by增加可能导致实际吸入NO浓度低于预设值。
  • 需监测NO2浓度,19%的配置中NO2≥0.3 ppm,该浓度可致支气管收缩。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Nitric oxide (NO) is a strong vasodilator, selectively directed on pulmonary circulation through inhaled administration. In adult intensive care units (ICU), it is mainly used for refractory hypoxemia in mechanically ventilated patients. Several medical delivery devices have been developed to deliver inhaled nitric oxide (iNO). The main purpose of those devices is to guarantee an accurate inspiratory NO concentration, whatever the ventilator used, with NO2 concentrations lower than 0.3 ppm. We hypothesized that the performances of the different available iNO delivery systems could depend on their working principle and could be influenced by the ventilator settings. The objective of this study was to assess the accuracy of seven different iNO-devices combined with different ICU ventilators' flow-by to reach inspiratory NO concentration targets and to evaluate their potential risk of toxicity.

METHODS: We tested seven iNO-devices on a test-lung connected to distinct ICU ventilators offering four different levels of flow-by. We measured the flow in the inspiratory limb of the patient circuit and the airway pressure. The nitric oxide/nitrogen (NO/N2) flow was measured on the administration line of the iNO-devices. NO and NO2 concentrations were measured in the test-lung using an electrochemical analyzer.

RESULTS: We identified three iNO-device generations based on the way they deliver NO flow: "Continuous", "Sequential to inspiratory phase" (I-Sequential) and "Proportional to inspiratory and expiratory ventilator flow" (Proportional). Median accuracy of iNO concentration measured in the test lung was 2% (interquartile range, IQR -19; 36), -23% (IQR -29; -17) and 0% (IQR -2; 0) with Continuous, I-Sequential and Proportional devices, respectively. Increased ventilator flow-by resulted in decreased iNO concentration in the test-lung with Continuous and I-Sequential devices, but not with Proportional ones. NO2 formation measured to assess potential risks of toxicity never exceeded the predefined safety target of 0.5 ppm. However, NO2 concentrations higher than or equal to 0.3 ppm, a concentration that can cause bronchoconstriction, were observed in 19% of the different configurations.

CONCLUSION: We identified three different generations of iNO-devices, based on their gas administration modalities, that were associated with highly variable iNO concentrations' accuracy. Ventilator's flow by significantly impacted iNO concentration. Only the Proportional devices permitted to accurately deliver iNO whatever the conditions and the ventilators tested.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Vuillermoz A, Lefranc M, Prouvez N, et al. Modes of administration of nitric oxide devices and ventilators flow-by impact the delivery of pre-determined concentrations. Ann Intensive Care. 2024. PMID: 39167232. doi:10.1186/s13613-024-01351-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。